Search

Displaying results 8431 - 8440 of 10000 in total
  1. Drug

    AT3022

    go.drugbank.com/drugs/DB05172
    Experimental

    AT3022, the Altea Therapeutics’s fentanyl citrate transdermal patch designed to provide safe and rapid management of moderate to severe chronic pain.

  2. Drug

    Naluzotan

    go.drugbank.com/drugs/DB05562
    Investigational

  3. Drug

    TC-2696

    go.drugbank.com/drugs/DB05576
    Experimental

    Synonyms: 5-(5-METHOXY-3-PYRIDINYL)-N-METHYL-4-PENTEN-2-AMINE, (2S,4E)-
  4. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. It is being developed by Vitae Pharmaceuticals.

  5. Drug

    Fedovapagon

    go.drugbank.com/drugs/DB11734
    Investigational

    Fedovapagon has been used in trials studying the treatment of Nocturia.

  6. Drug

    Cirtuvivint

    go.drugbank.com/drugs/DB17269
    Investigational

    Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.

    Synonyms: 4-pyridinecarboxamide, 2-(4-methyl-1-piperazinyl)-n-(6-(1-methyl-1h-pyrazol-4-yl)-3-isoquinolinyl)-
  7. Drug

    Apc001

    go.drugbank.com/drugs/DB17819
    Experimental

    Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta.

  8. Drug

    HLX-58

    go.drugbank.com/drugs/DB18699
    Experimental

    HLX-58 is an investigational monoclonal antibody targeted against claudin 18.2.

  9. Drug

    BA1301

    go.drugbank.com/drugs/DB19390
    Investigational

    BA1301 is an anti-Claudin18.2 monoclonal antibody conjugated with Duostatin-5.

  10. Drug

    Daniquidone

    go.drugbank.com/drugs/DB12804
    Investigational

    Daniquidone has been used in trials studying the treatment of Neoplasms.